The study will measure the impact of Cognixion's novel combination of BCI, AI and AR technology on the ability of amyotrophic lateral sclerosis ...

Axon Enterprise forecast its annual revenue above estimates on Tuesday, following robust quarterly results, banking on sustained strong demand for its software products and TASER devices.

Cognixion announced today that it launched a clinical trial evaluating its integrated, wearable augmented reality and BCI ...